284 related articles for article (PubMed ID: 24719055)
1. New and emerging treatments for hyperpigmentation.
Alexis AF
J Drugs Dermatol; 2014 Apr; 13(4):382-5. PubMed ID: 24719055
[TBL] [Abstract][Full Text] [Related]
2. [Topical treatment of hyperpigmentation disorders].
Rendon M; Horwitz S
Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S102-7. PubMed ID: 23260517
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Insights in Melasma and Hyperpigmentation Management.
Huerth KA; Hassan S; Callender VD
J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment of hyperpigmentation disorders.
Rendon M; Horwitz S
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
[TBL] [Abstract][Full Text] [Related]
5. The role of systemic treatments for skin lightening.
Juhasz MLW; Levin MK
J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
[TBL] [Abstract][Full Text] [Related]
6. Postinflammatory hyperpigmentation in patients with skin of color.
Shokeen D
Cutis; 2016 Jan; 97(1):E9-E11. PubMed ID: 26919365
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
[TBL] [Abstract][Full Text] [Related]
10. Topical treatments for melasma and postinflammatory hyperpigmentation.
Lynde CB; Kraft JN; Lynde CW
Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
[TBL] [Abstract][Full Text] [Related]
11. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperpigmentation.
Woolery-Lloyd H; Kammer JN
Semin Cutan Med Surg; 2011 Sep; 30(3):171-5. PubMed ID: 21925372
[TBL] [Abstract][Full Text] [Related]
13. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
Sofen B; Prado G; Emer J
Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
[TBL] [Abstract][Full Text] [Related]
15. What's New in Pigmentary Disorders.
Zubair R; Lyons AB; Vellaichamy G; Peacock A; Hamzavi I
Dermatol Clin; 2019 Apr; 37(2):175-181. PubMed ID: 30850040
[TBL] [Abstract][Full Text] [Related]
16. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
17. [Topical treatment of pigmentation disorders with cosmetic and pharmaceutical agents].
Kerscher M; Buntrock H
Hautarzt; 2020 Dec; 71(12):944-949. PubMed ID: 33146766
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of novel topical pigment-correcting regimen with biweekly diamond tip microdermabrasion procedures on facial hyperpigmentation.
Goberdhan L; Schneider K; Makino ET; Bautista A; Mehta RC
J Cosmet Dermatol; 2024 May; 23(5):1726-1733. PubMed ID: 38288515
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
Fabi SG; Goldman MP
J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
[TBL] [Abstract][Full Text] [Related]
20. Acne in ethnic skin: special considerations for therapy.
Callender VD
Dermatol Ther; 2004; 17(2):184-95. PubMed ID: 15113286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
